| Marc Espy Rankin, MD | |
|
3301 New Mexico Ave Nw Ste 248, Washington, DC 20016-3610 | |
| (202) 244-0706 | |
| (202) 686-6278 |
| Full Name | Marc Espy Rankin |
|---|---|
| Gender | Male |
| Speciality | Orthopedic Surgery |
| Experience | 27 Years |
| Location | 3301 New Mexico Ave Nw Ste 248, Washington, District Of Columbia |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1760480222 | NPI | - | NPPES |
| 034937200 | Medicaid | DC |
| Facility Name | Location | Facility Type |
|---|---|---|
| Amedisys Home Health Care | Largo, MD | Home health agency |
| Sibley Memorial Hospital | Washington, DC | Hospital |
| Medstar Washington Hospital Center | Washington, DC | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Centers For Advanced Orthopaedics Llc | 8123260981 | 476 |
News Archive
Nerve cells relay messages at blink-of-the-eye speeds by squirting chemicals called neurotransmitters across tiny gaps called synapses to awaiting message receptors. But lots of different receptors and neurotransmitters work simultaneously. Which goes where to send the proper message?
A federal appeals court on Tuesday ordered a major health system in northwest Ohio to unwind its merger with a local hospital on antitrust grounds. The unanimous decision by a three-judge panel of the Sixth U.S. Circuit Court of Appeals in Cincinnati comes amid growing concerns about hospital mergers and their effect on prices against the backdrop of America's health care upheaval (Gershman, 4/22).
ACCESS PHARMACEUTICALS, INC., a biopharmaceutical company leveraging its proprietary drug-delivery platforms to develop treatments in areas of oncology, cancer supportive care and diabetes, has entered into definitive agreements with existing and new accredited investors to sell, in a registered direct offering, an aggregate of approximately 2.3 million shares of its common stock at a price of $2.55 per share for aggregate gross proceeds of $6.0 million.
A new world-class orthopaedic gait analysis laboratory - the ‘GRAIL' (gait real-time analysis interactive laboratory) - and state-of-the-art virtual reality training equipment have been installed at Bournemouth University's Orthopaedic Research Institute thanks to a £700,000 local growth fund investment secured by Dorset Local Enterprise Partnership.
Five-year data from a study evaluating the use of docetaxel (Taxotere) administered after cisplatin/etoposide chemotherapy plus radiation therapy demonstrate the best long-term survival rates reported in patients with locally advanced (Stage IIIB) non-small cell lung cancer (NSCLC).
› Verified 8 days ago
| Entity Name | Centers For Advanced Orthopaedics Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1487093167 PECOS PAC ID: 8123260981 Enrollment ID: O20131024001780 |
News Archive
Nerve cells relay messages at blink-of-the-eye speeds by squirting chemicals called neurotransmitters across tiny gaps called synapses to awaiting message receptors. But lots of different receptors and neurotransmitters work simultaneously. Which goes where to send the proper message?
A federal appeals court on Tuesday ordered a major health system in northwest Ohio to unwind its merger with a local hospital on antitrust grounds. The unanimous decision by a three-judge panel of the Sixth U.S. Circuit Court of Appeals in Cincinnati comes amid growing concerns about hospital mergers and their effect on prices against the backdrop of America's health care upheaval (Gershman, 4/22).
ACCESS PHARMACEUTICALS, INC., a biopharmaceutical company leveraging its proprietary drug-delivery platforms to develop treatments in areas of oncology, cancer supportive care and diabetes, has entered into definitive agreements with existing and new accredited investors to sell, in a registered direct offering, an aggregate of approximately 2.3 million shares of its common stock at a price of $2.55 per share for aggregate gross proceeds of $6.0 million.
A new world-class orthopaedic gait analysis laboratory - the ‘GRAIL' (gait real-time analysis interactive laboratory) - and state-of-the-art virtual reality training equipment have been installed at Bournemouth University's Orthopaedic Research Institute thanks to a £700,000 local growth fund investment secured by Dorset Local Enterprise Partnership.
Five-year data from a study evaluating the use of docetaxel (Taxotere) administered after cisplatin/etoposide chemotherapy plus radiation therapy demonstrate the best long-term survival rates reported in patients with locally advanced (Stage IIIB) non-small cell lung cancer (NSCLC).
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Marc Espy Rankin, MD 3301 New Mexico Ave Nw Ste 248, Washington, DC 20016-3610 Ph: (202) 244-0706 | Marc Espy Rankin, MD 3301 New Mexico Ave Nw Ste 248, Washington, DC 20016-3610 Ph: (202) 244-0706 |
News Archive
Nerve cells relay messages at blink-of-the-eye speeds by squirting chemicals called neurotransmitters across tiny gaps called synapses to awaiting message receptors. But lots of different receptors and neurotransmitters work simultaneously. Which goes where to send the proper message?
A federal appeals court on Tuesday ordered a major health system in northwest Ohio to unwind its merger with a local hospital on antitrust grounds. The unanimous decision by a three-judge panel of the Sixth U.S. Circuit Court of Appeals in Cincinnati comes amid growing concerns about hospital mergers and their effect on prices against the backdrop of America's health care upheaval (Gershman, 4/22).
ACCESS PHARMACEUTICALS, INC., a biopharmaceutical company leveraging its proprietary drug-delivery platforms to develop treatments in areas of oncology, cancer supportive care and diabetes, has entered into definitive agreements with existing and new accredited investors to sell, in a registered direct offering, an aggregate of approximately 2.3 million shares of its common stock at a price of $2.55 per share for aggregate gross proceeds of $6.0 million.
A new world-class orthopaedic gait analysis laboratory - the ‘GRAIL' (gait real-time analysis interactive laboratory) - and state-of-the-art virtual reality training equipment have been installed at Bournemouth University's Orthopaedic Research Institute thanks to a £700,000 local growth fund investment secured by Dorset Local Enterprise Partnership.
Five-year data from a study evaluating the use of docetaxel (Taxotere) administered after cisplatin/etoposide chemotherapy plus radiation therapy demonstrate the best long-term survival rates reported in patients with locally advanced (Stage IIIB) non-small cell lung cancer (NSCLC).
› Verified 8 days ago
Fred Mo, MD Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 3800 Reservoir Rd Nw, Washington, DC 20007 Phone: 202-444-8766 Fax: 202-444-1655 | |
Dr. Panagiotis A Labropoulos, MD Orthopedic Surgery Medicare: Not Enrolled in Medicare Practice Location: 2150 Pennsylvania Ave Nw, 7th Floor, Washington, DC 20037 Phone: 202-741-3305 Fax: 202-741-3313 | |
Dr. Harvey M. Cohen, M. D. Orthopedic Surgery Medicare: Medicare Enrolled Practice Location: Walter Reed Army Medical Ctr, Washington, DC 20307 Phone: 202-782-0292 Fax: 202-782-6845 | |
Olivia Mae Larussa, PA-C Orthopedic Surgery Medicare: Medicare Enrolled Practice Location: 900 23rd St Nw, Washington, DC 20037 Phone: 202-741-3000 | |
Dr. Craig Robert Faulks, M.D. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 3 Washington Cir Nw, Suite 404, Washington, DC 20037 Phone: 202-333-2820 Fax: 202-833-1410 | |
Dr. Melinda Miller Gardner, M.D. Orthopedic Surgery Medicare: Not Enrolled in Medicare Practice Location: 3301 New Mexico Ave Nw, Ste 248, Washington, DC 20016 Phone: 202-244-0706 Fax: 202-686-6278 | |
Shannon Mcclure Kelly, MD Orthopedic Surgery Medicare: Medicare Enrolled Practice Location: 111 Michigan Ave Nw, Orthopaedic Surgery, Washington, DC 20010 Phone: 202-476-4063 Fax: 202-476-4613 |